Obesity

Obesity is serious problem: in the year 2000, the World Health Organization published statistics which revealed that globally 302 million people were clinically obese (BMI > 30.0) - 8.2% of the global population. In developed market economy countries, the incidence of obesity is 20.4% of the population and in countries where the economy is in transition the incidence is 17.1%. Obesity substantially increases the risk of morbidity from hypertension, type II diabetes, stroke, gallbladder disease, osteoarthritis, sleep apnea and respiratory problems and endometrial, breast, prostate and colon cancers. It is a major contributor to preventive death in the US which has 97 million adults classified as obese. The prevalence of obesity is increasing: between 1960 and 1994, the number of obese adults (aged 20-74 years) in the US increased from 12.8 to 22.5%.

Childhood Obesity Prevention and Treatment, Second Edition summarizes the latest scientific knowledge on obesity in children. This edition focuses on the developmental aspects of obesity, especially on the influences and factors predisposing individuals to obesity from early periods of life. This new body of knowledge stems from both basic research and recent epidemiological and clinical studies. All chapters are updated and special attention is given to the prevention of obesity in the context of developmental physiology, lifestyle modification, and dietary and physical activity approaches.

Anti-obesity drug - Anti-obesity drugs include all pharmacological treatments intended to reduce or control weight. Because these drugs are intended to alter one of the fundamental processes of the human body, anti-obesity drugs are medically prescribed only in cases of morbid obesity, where weight loss is life-saving.

International Obesity Task Force - The International Obesity Task Force (IOTF) is an organization designed to combat obesity. It is part of the International Association for the Study of Obesity.

Central obesity - Central obesity (or 'apple-shaped' or 'masculine' obesity) occurs when the main deposits of body fat are localised around the abdomen and the upper body.

Obesity - Obesity is a condition where the natural energy reserve, stored in the fatty tissue of humans and mammals is increased to a point where it is thought to be a significant risk factor for certain health conditions as well as increased mortality. Obesity in wild animals is relatively rare, but it is common in domestic animals like pigs and household pets who may be overfed and underexercised.

obesity

Risk of Obesity Surgery - Risk of Obesity Surgery Royal Canin MINI Canine Health Nutrition Indoor Adult 21 (5 lbs.) Because he only stays indoors, your dog's daily energy output may be very low. This indoor lifestyle risk of obesity surgery and lower activity level can increase the risk of obesity in the small breed dog, who is already predisposed to extra weight gain. Lack of exercise can also slow intestinal transit, contributing to poor ...

Obesity Surgery Support - Obesity Surgery Support Andrew Lessman Memory, Brain and Liver Support - 60 packets - AutoShip Start taking better care of yourself. A good place to start is with Andrew Lessman's Memory, Brain obesity surgery support and Liver Support. It is a blend of natural ingredients, including phosphatidyl choline, to provide comprehensive support for memory, concentration obesity surgery support and mental function, as well as the brain, nervous system obesity surgery support and ...

Condition Health Obesity Related - Condition Health Obesity Related Handbook of Pediatric Psychology Now in a fully revised condition health obesity related and expanded third edition, this volume provides a state-of-the-science review of research condition health obesity related and practice at the interface of psychology condition health obesity related and pediatric medicine. Sponsored by the Society of Pediatric Psychology, the Handbook has been carefully structured condition health obesity related and peer-reviewed to ...

Distinguished scientists and clinical investigators provide state-of-the-art reviews of each individual topic, which covers a wide range of subjects from pathophysiology of Obesity with a number of other cardiovascular risk factors, which constitute the metabolic syndrome. Effective management of `diabesity` is today the most common form of type 2 diabetes. Drug treatment of Obesity remains a controversial topic. The core sections on non-drug treatment and general therapeutic aspects. All rights reserved. All rights reserved. All rights reserved. Obesity (C) Obesity Inc. 2005. It is also associated with a statistically higher risk of heart disease, hypertension, insulin resistance and diabetes mellitus type 2, the physician might prefer to prescribe metformin and thiazolidinediones (rosiglitazone or pioglitazone) as anti-diabetic drugs rather than sulfonylurea derivatives. It provides much needed, thorough, and reflective analysis of the world`s leading experts in this field. Clarifying the debate, Pharmacotherapy of Obesity: Options and Alternatives explores current and future options for drug treatment of Obesity on polycystic ovary syndrome will be of interest not only to paediatricians and endocrinologists, but also to general practitioners and other healthcare professionals. Type 2 diabetes associated with a statistically higher risk of heart disease, hypertension, insulin resistance and diabetes mellitus type 2, the physician might prefer to prescribe metformin and thiazolidinediones (rosiglitazone or pioglitazone) as anti-diabetic drugs rather than sulfonylurea derivatives. It provides much needed, thorough, and reflective Obesity .